Primary Cutaneous B-cell Lymphomas.
Hope CB, Pincus LB.
Clin Lab Med. 2017 Sep;37(3):547-574. doi: 10.1016/j.cll.2017.05.009.
Lymphoma classification update: B-cell non-Hodgkin lymphomas.
Jiang M, Bennani NN, Feldman AL.
Expert Rev Hematol. 2017 May;10(5):405-415. doi: 10.1080/17474086.2017.1318053. Epub 2017 Apr 24.
T-cell/histiocyte-rich B-cell lymphoma: biology, diagnosis, and management.
Abramson JS.
Oncologist. 2006 Apr;11(4):384-92. doi: 10.1634/theoncologist.11-4-384.
Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapy.
Jamil MO, Mehta A.
Expert Rev Hematol. 2016 May;9(5):471-7. doi: 10.1586/17474086.2016.1146584. Epub 2016 Feb 19.
Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.
Bellan C, Stefano L, Giulia de F, Rogena EA, Lorenzo L.
Hematol Oncol. 2010 Jun;28(2):53-6. doi: 10.1002/hon.916.
Primary mediastinal large B-cell lymphoma.
Savage KJ.
Oncologist. 2006 May;11(5):488-95. doi: 10.1634/theoncologist.11-5-488.
Appropriate management of molecular subtypes of diffuse large B-cell lymphoma.
Dunleavy K, Wilson WH.
Oncology (Williston Park). 2014 Apr;28(4):326-34.
Resected Diffuse Large B Cell Lymphoma: Does Extirpation Mean No Irradiation in the PET-Response Based Milieu?
McMullen KP, Sawyer J.
Int J Radiat Oncol Biol Phys. 2024 Jul 1;119(3):716-717. doi: 10.1016/j.ijrobp.2024.01.207.
Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment.
Crombie JL, Armand P.
Hematol Oncol Clin North Am. 2019 Aug;33(4):575-585. doi: 10.1016/j.hoc.2019.03.001. Epub 2019 May 18.
Diffuse large B-cell lymphoma of the anterior abdominal wall.
Sia ZK, Beck MD.
Aust J Gen Pract. 2023 May;52(5):303-305. doi: 10.31128/AJGP-07-22-6503.
